For nearly 30 years, AAMDSIF has provided financial support for research that leads to new insights into the causes of bone marrow disorder diseases and to the development of new therapeutic approaches. Since 1989, we have awarded over $4 million in funding to national and international biomedical researchers.
2019 AAMDSIF Grant Cycle Now Open
- Expanded scope
In addition to acquired aplastic anemia, MDS and PNH, applications may include MDS transition to AML, MDS/MPN overlap such as CMML, and PRCA
- Required Letter of Intent (LOI)
LOIs are required prior to submission of full application. Applicants will be invited to submit a full application based on the LOI. Deadline extended until February 28, 2019!
- Poster Presentation
Grantees are required to present their work at the AAMDSIF Scientific Symposium, held every two years. Travel stipends may be available for international grantees.
Full application criteria and instructions are available here.
2019 AAMDSIF Letter of Intent (LOI) is available through ProposalCENTRAL. If you don’t already have an account with ProposalCENTRAL, you can create one using the link provided.
We look forward to an exciting 2019 grant cycle. Questions may be directed to Alice Houk, Senior Director of Health Professional Programs at email@example.com